Free Trial

Morgan Stanley: Macro Weakness, Regulatory Headwinds

CHINA STOCKS

Morgan Stanley note that they have cut their "June '22 base case index targets for Chinese equities to 90 for MSCI China (-3% vs. 14 Sep '21 close), 5,100 for the CSI 300 (+4% vs. 14 Sep '21 close), 24,400 for the Hang Seng (-4% vs. 14 Sep '21 close) and 8,750 for the HSCEI (-4% vs. 14 Sep '21 close). This move is mainly driven by reductions in earnings growth forecasts for '21 and '22, as a result of macro headwinds and regulatory reset's impact on margins. We stay cautious on Chinese equities and continue to prefer A-shares to offshore China."

  • "Our economics team for China has reduced its '21 GDP growth forecast twice, to 8.2% recently, and has just cut its Q3 GDP Y/Y growth outlook by 60bp, to 4.5%. Recurrence of local/regional COVID outbreaks has hindered the recovery of private consumption and services. August retail sales data were greatly disappointing. The overall tightening policy since November '20 and elevated PPI level have put pressure on margins and corporate investment, as seen in recent subdued PMI readings."
  • "As regulatory reset transitions into the implementation phase, we believe the recent developments in cybersecurity, antitrust, and data privacy would curb margins and earnings growth for affected sectors. Uncertainty remains on how to quantify the broader objectives of regulatory reset in key sectors, and we suspect this is not yet fully discounted in stock prices."
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.